Search Results 1161-1170 of 19944 for Receptor
Use of a corticotropin-releasing factor receptor antagonist within 14 days of Screening. Note: Other protocol defined Inclusion/Exclusion Criteria may apply ...
Men or women of childbearing potential who are unwilling to employ adequate contraception. Use of ACE inhibitors (including lisinopril) or ACE receptor blockers ...
The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer No Locations. The ...
Nursing care throughout the chimeric antigen receptor T-cell therapy process for multiple myeloma. Seminars in Oncology Nursing. 2023; doi:10.1016/j.soncn ...
Billadeau's lab is on understanding receptor trafficking through the endosomal system by the Wiskott-Aldrich syndrome protein and SCAR homolog (WASH) ...
... receptor agonists and SGLT2 inhibitors. Ask your health care professional if treatments such as SGLT2 inhibitors or GLP-1 receptor agonists might work for you.
... receptor binding and antigenicity. Unlike the human H3 influenza virus strains, the equine virus isolates have no close relatives in other species and ...
Group 1 (TP-0903 monotherapy): Patients with CLL/SLL who are intolerant to, or have progressed on B-cell receptor antagonists and/or BCL-2 antagonists; or ...
... receptor positive (ER+/PR+, and Her2-) metastatic breast cancer, recurrent GBM, GASTRIC/GASTROESOPHAGEAL JUNCTION CANCER, advanced pancreatic adenocarcinoma ...
Small molecule receptor tyrosine kinase inhibitor (TKI) therapy (including investigational) within 2 weeks or 5 half-lives, whichever is longer;; Any type of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.